Moderna says its low-dose COVID vaccine generates immune response in kids
![Justin Lemus, 15, posed for a photo with his vaccination sticker after being inoculated with the first dose of the Pfizer COVID-19 vaccine at the Mount Sinai South Nassau Vaxmobile parked at the De La Salle School, Friday, May 14, 2021, in Freeport, N.Y. The De La Salle School partnered with the Vaxmobile Friday to help Long Island students 12 and over receive the first dose of the Pfizer COVID-19 vaccine as part of Mount Sinai South Nassau's mobile vaccination program. Virus Outbreak New York Vaccine Kids](https://i.cbc.ca/1.6224008.1635178805!/fileImage/httpImage/image.jpg_gen/derivatives/16x9_460/virus-outbreak-new-york-vaccine-kids.jpg)
Moderna says its clinical trials with children aged six to 11 showed two doses that were half the size of its adult shots produced similar levels of virus-fighting antibodies in children.
Comments
Post a Comment